Inspire Medical Systems, Inc. revised revenue guidance for the full year 2023. For the year, the company expects revenue guidance to between $608 million to $612 million, which represents growth of 49% to 50% over full year 2022 revenue of $407.9 million. This compares to the prior revenue guidance of $600 million to $610 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
158.6 USD | -0.63% | -35.44% | -22.04% |
05-08 | Top Premarket Decliners | MT |
05-07 | Transcript : Inspire Medical Systems, Inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.04% | 4.74B | |
+8.29% | 124B | |
-5.61% | 11.02B | |
+4.83% | 8.88B | |
+39.60% | 5.45B | |
+8.39% | 3.44B | |
-6.28% | 2.84B | |
-10.23% | 2.15B | |
-5.99% | 2.11B | |
-22.62% | 1.79B |
- Stock Market
- Equities
- INSP Stock
- News Inspire Medical Systems, Inc.
- Inspire Medical Systems, Inc. Revises Revenue Guidance for the Full Year 2023